| Financial Year |
March 31 2023 |
| Monetary Funds |
853,844,610.15 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
468,295,665.50 |
| Accounts Receivable |
1,603,152,057.97 |
| Advances to Suppliers |
194,298,154.06 |
| Other Receivables |
35,163,339.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,751,127.55 |
| Inventories |
1,275,316,729.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
15,715,631.52 |
| Other Current Assets |
33,794,186.00 |
| Total Current Assets |
4,775,343,556.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,162,458.90 |
| Long-term Equity Investment |
566,321,122.40 |
| Investment Properties |
113,886,774.36 |
| Fixed Assetes |
1,196,467,911.57 |
| Under-construction Projects |
129,783,279.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
166,422,187.16 |
| R&D expenses |
-- |
| Goodwill |
248,345,508.41 |
| Long-Term Deferred and Prepaid Expenses |
6,428,525.17 |
| Deferred Income Tax Assets |
99,895,347.56 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,718,532,398.01 |
| Total Assets |
7,493,875,954.26 |
| Short-Term Loans |
300,142,121.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
657,829,792.74 |
| Accounts Payable |
1,543,630,846.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
41,063,233.44 |
| Taxes Payable |
35,694,840.09 |
| Interest Payable |
-- |
| Dividend Payable |
533,156.00 |
| Other payables |
32,645,482.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
66,488,644.67 |
| Other Current Liabilities |
198,040,125.75 |
| Sub-Total of Current Liabilities |
3,475,462,194.97 |
| Long-term Loans |
715,100,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
31,948,205.66 |
| Special Payable |
-- |
| Estimatied Liabilities |
18,588,480.94 |
| Deferred Income Tax Liabilities |
54,004,297.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
932,529,300.37 |
| Total Liabilities |
4,407,991,495.34 |
| Paid-In Capital(Or Share Stock) |
843,212,507.00 |
| Capital Surplus |
717,097,098.38 |
| Surplus Reserve |
825,226,634.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
643,838,316.12 |
| Minority Stockholder's Interest |
54,301,233.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,031,583,225.38 |
| Owner's Equity（Stockholder's Equity） |
3,085,884,458.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,493,875,954.26 |
